Bladder cancer secondary prevention

Jump to: navigation, search

Bladder cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Bladder cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Electrocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bladder cancer secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bladder cancer secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bladder cancer secondary prevention

CDC on Bladder cancer secondary prevention

Bladder cancer secondary prevention in the news

Blogs on Bladder cancer secondary prevention

Directions to Hospitals Treating Bladder cancer

Risk calculators and risk factors for Bladder cancer secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]

Overview

Effective measures for the secondary prevention of bladder cancer include early screening and early intervention of treatment.

Secondary Prevention

References

  1. Leppert JT, Shvarts O, Kawaoka K, Lieberman R, Belldegrun AS, Pantuck AJ (February 2006). "Prevention of bladder cancer: a review". Eur. Urol. 49 (2): 226–34. doi:10.1016/j.eururo.2005.12.011. PMID 16413099.
  2. Al-Zalabani AH, Stewart KF, Wesselius A, Schols AM, Zeegers MP (September 2016). "Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses". Eur. J. Epidemiol. 31 (9): 811–51. doi:10.1007/s10654-016-0138-6. PMC 5010611. PMID 27000312.

Linked-in.jpg